Literature DB >> 1682071

Leukocyte sonicates as a source for both enzyme assay and DNA amplification for mutational analysis of certain lysosomal disorders.

E Louie1, M A Rafi, D A Wenger.   

Abstract

At present the identification of patients and carriers of most lysosomal disorders is accomplished by finding decreased activity of one enzyme in an easily obtained tissue sample such as leukocytes. As the genes for these enzymes are cloned and mutations identified, the use of molecular techniques to supplement enzyme testing will be warranted. To facilitate the implementation of such studies a simple method for isolating DNA from the remaining leukocyte sonicate, and using this DNA for polymerase chain reaction amplification of regions involved in three lysosomal disorders is described. The DNA from the sonicate was isolated without proteinase K digestion, was readily soluble in Tris-EDTA buffer and available for amplification almost immediately. The usefulness of the methods was confirmed by studies on patients and family members with three relatively common lysosomal disorders, metachromatic leukodystrophy. Gaucher disease and Tay-Sachs disease. This method allows immediate DNA analysis without the need for securing an additional blood sample.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682071     DOI: 10.1016/0009-8981(91)90003-u

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

1.  Metachromatic leukodystrophy among southern Alaskan Eskimos: molecular and genetic studies.

Authors:  N M Pastor-Soler; E M Schertz; M A Rafi; G de Gala; D A Wenger
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

2.  Mutations in the lysosomal beta-galactosidase gene that cause the adult form of GM1 gangliosidosis.

Authors:  S Chakraborty; M A Rafi; D A Wenger
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.